Hyson C P, Kazakoff M A
Family Practice Residency Program of Middlesex Memorial Hospital, Middletown, Conn.
Arch Intern Med. 1991 Feb;151(2):387-8.
We present a case of a severe reaction to sulindac. A 30-year-old woman with quiescent systemic lupus erythematosus received sulindac for nonspecific migrating chest pain. An initial course of therapy produced an unrecognized sensitization to the drug with a febrile illness and rash. Readministration of the drug caused an anaphylactoid reaction as well as evidence of cardiovascular, hepatic, pulmonary, and hematologic dysfunction. The patient's illness had evidence of types I, II, and III hypersensitivity reactions.
我们报告一例对舒林酸的严重反应。一名患有静止性系统性红斑狼疮的30岁女性因非特异性游走性胸痛接受舒林酸治疗。初始疗程导致对该药物产生未被识别的致敏反应,出现发热性疾病和皮疹。再次给药引发类过敏反应以及心血管、肝脏、肺部和血液系统功能障碍的证据。该患者的病情有I型、II型和III型超敏反应的迹象。